Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CBNT | Series B Convertible Preferred Stock | Award | $162K | +162 | +81% | $1,000.00* | 362 | Jan 2, 2024 | Common Stock | 27M | $0.01 | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | On December 7, 2023, the Board of Directors ("Board") of the Company awarded an annual bonus for 2023 to Ms. Tomek in the amount of $180,000, 10% of which was to be paid in cash, and 90% of which was to be paid in the Company's equity. On January 2, 2024, the Board approved paying 90% of Ms. Tomek's 2023 bonus in the Company's Series B Convertible Preferred Stock, par value $0.10 ("Series B"). Ms. Tomek received 162 shares of Series B, which has a stated value of $1,000 per share. The Series B is convertible into shares of common stock, par value $0.001 ("Common Stock"), at $0.006 per share, the closing trading price of the Common Stock on the date before the grant, subject to adjustment as described in the Company's Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock. |
F2 | The shares of Series B granted to Ms. Tomek vest on May 1, 2025, subject to extension as mutually agreed upon by the Board and Ms. Tomek. |
F3 | No expiration date. |